Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival : an analysis of 10 549 patients from the International Myeloma Working Group

Heinz Ludwig,1 Brian G. M. Durie,2 Vanessa Bolejack,3 Ingemar Turesson,4 Robert A. Kyle,5 Joan Blade,6 Rafael Fonseca,7 Meletios Dimopoulos,8 Kazuyuki Shimizu,9 Jesus San Miguel,10 Jan Westin,11 Jean-Luc Harousseau,12 Meral Beksac,13 Mario Boccadoro,14 Antonio Palumbo,14 Bart Barlogie,15 Chaim Shustik,16 Michele Cavo,17 Philip R. Greipp,5 Douglas Joshua,18 Michel Attal,19 Pieter Sonneveld,20 and John Crowley3

[1]  H. Brenner,et al.  Recent major improvement in long-term survival of younger patients with multiple myeloma. , 2008, Blood.

[2]  P. Dickman,et al.  Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  H. Kaufmann,et al.  Chromosomal abnormalities of young multiple myeloma patients (<45 yr) are not different from those of other age groups and are independent of stage according to the International Staging System , 2007, European journal of haematology.

[4]  U. Mellqvist,et al.  Impact of age on survival after intensive therapy for multiple myeloma: a population‐based study by the Nordic Myeloma Study Group , 2006, British journal of haematology.

[5]  G. Morgan,et al.  Age has a profound effect on the incidence and significance of chromosome abnormalities in myeloma , 2005, Leukemia.

[6]  J. Crowley,et al.  International staging system for multiple myeloma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  Paul W Dickman,et al.  Regression models for relative survival , 2004, Statistics in medicine.

[8]  S. Vincent Rajkumar,et al.  Promising preclinical activity of 2-methoxyestradiol in multiple myeloma. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[9]  M. Höglund,et al.  Cytogenetic features of multiple myeloma: impact of gender, age, disease phase, culture time, and cytokine stimulation , 2002, European journal of haematology.

[10]  I. Bleiweiss,et al.  Stage 0 to stage III breast cancer in young women. , 2000, Journal of the American College of Surgeons.

[11]  D. O'shaughnessy,et al.  Recent advances in haematology , 1999, BMJ.

[12]  R. Kyle,et al.  Multiple myeloma in young patients: clinical presentation and treatment approach. , 1998, Leukemia & lymphoma.

[13]  C. Klersy,et al.  Multiple myeloma in younger patients: the role of age as prognostic factor , 1998, Annals of Hematology.

[14]  R. Kyle,et al.  Multiple myeloma in patients younger than 30 years. Report of 10 cases and review of the literature. , 1996, Archives of internal medicine.

[15]  R. Kyle,et al.  Presenting Features and Prognosis in 72 Patients With Multiple Myeloma Who Were Younger Than 40 Years , 1996, British journal of haematology.

[16]  D. Bergsagel.  The incidence and epidemiology of plasma cell neoplasms. , 1995, Stem cells.

[17]  G. Tjønnfjord,et al.  Has the incidence of multiple myeloma in old age been underestimated? , 1991, European journal of haematology.

[18]  M. Gobbi,et al.  Prognostic variables and clinical staging in multiple myeloma. , 1989, Blood.

[19]  H. Ludwig,et al.  Epidemiologic and age-dependent data on multiple myeloma in Austria. , 1982, Journal of the National Cancer Institute.

[20]  N. Mantel.  Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.

[21]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[22]  E. Feuer,et al.  SEER Cancer Statistics Review, 1975-2003 , 2006 .

[23]  T. Buchler,et al.  Prognostic factors for survival after autologous transplantation: a single centre experience in 133 multiple myeloma patients , 2005, Bone Marrow Transplantation.

[24]  H. Heimpel,et al.  Gender aspects in chronic myeloid leukemia: long-term results from randomized studies , 2005, Leukemia.

[25]  W. Hiddemann,et al.  Population-based age-specific incidences of cytogenetic subgroups of acute myeloid leukemia. , 2005, Haematologica.

[26]  Terry M Therneau,et al.  Review of 1027 patients with newly diagnosed multiple myeloma. , 2003, Mayo Clinic proceedings.

[27]  B. Barlogie,et al.  Age is not a prognostic variable with autotransplants for multiple myeloma. , 1999, Blood.

[28]  R. Kyle.  Multiple myeloma: review of 869 cases. , 1975, Mayo Clinic proceedings.

[29]  D.,et al.  Regression Models and Life-Tables , 2022 .